Axcelius I/II

Argobio Studio

This startup studio develops therapeutic biotechnology companies by incubating early-stage research projects for patients with oncology, immunology, and neurological disorders.

Arclight Therapeutics

This biopharmaceutical incubator provides research resources and operational support to early-stage companies developing treatments for neurodegenerative diseases.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.

Crucible Therapeutics

This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

QurAlis

This company develops precision medicines for patients with amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.

Cereius

This company develops targeted radiopharmaceuticals and radiodiagnostics for cancer patients, focusing on the treatment of solid tumour brain metastases.

HuntX Pharma

This biotechnology firm develops oral small-molecule therapeutics targeting axonal transport defects to treat patients with Huntington's disease and other neurodegenerative disorders.